Fritextsökning
Artiklar per år
Innehållstyper
-
Tablet treatment for hair loss approved in the USA
The US Drug Administration has given a thumbs up for the first tablet treatment for spotty hair loss.
-
Collaboration for a simpler production of gene therapies launched
A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by Johan Rockberg, Professor at KTH.
-
Study: Our behaviour may have been guided by wishful thinking during the pandemic
A new study suggests that we systematically underestimate health risks if and when it suits us. This was especially true during the pandemic, as our risk assessments may have been guided by wishful thinking rather than a rational perception of the risks.
-
Palle Lundberg blir ny vd för SKR
Sveriges kommuner och regioner (SKR) anställer Palle Lundberg som ny verkställande direktör. Han tillträder den 1 oktober.
-
Ojämställt i toppen hos Uppsalas life science-företag
STUNS Life science i Uppsala har undersökt hur jämställdhet mellan man och kvinna ser ut i regionens life science-företag. Och trots att Sverige hör till ett av världens mest jämställda länder, är den kvinnliga representationen låg på ledningsposter i Uppsala.
-
Björn Arvidsson: “We need robust and recognized ecosystems for continued competitiveness”
“We have idea carriers and excellent innovation opportunities, and now we must invest in creating ecosystems that provide them with even better growth opportunities,” Björn Arvidsson writes in a column.
-
Marie Gårdmark: New incentives for orphan products on its way
"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave for drug development in a broader context", writes Marie Gårdmark in a column.
-
Astra Zeneca i Södertälje vinnare i stor internationell tävling
Astra Zeneca är vinnarna i årets Acceligov Challenge och därmed blir läkemedelsbolagets anläggning i Södertälje pilotanläggning för en ny miljövänlig teknik för att rena avloppsvatten. "Det känns oerhört hedrande att bli utsedda till vinnare i Leading Cities Acceligov-tävling", säger Nina Andrén, chef för Astra Zenecas campus i Södertälje till Life Science Sweden.
-
A growing industry in Denmark: “One new life science company a week”
The life science sector in eastern Denmark continues to grow in the number of employees, as well as the number of companies. An emerging problem is the shortage of labour, a new report reveals.
-
IVI’s Director General on establishing in Sweden: Will need up to 40 employees
The International Vaccine Institute, IVI, hopes to have its first staff on-site in Stockholm within a couple of months, says the institute’s Director General Jerome Kim in an interview with Life Science Sweden.
-
The first vaccine derived from cowpox
The British rural doctor could not forget the words of the peasant girl. Could that really be true? A couple of decades later, on 14 May 1796, he performed the world’s first smallpox vaccination, and a medical breakthrough had occurred.
-
Now it’s settled: The International Vaccine Institute will be located in Stockholm
The International Vaccine Institute, IVI, is establishing itself outside South Korea for the first time. Last week, the Swedish Parliament ratified the agreement, which means that a branch of the institute will be located in Stockholm.
-
Start-up developing ”digital twin” received award during the EIT Health Summit
A biotech company, a medtech company and a company in digital health were on the podium when the EIT Health Catapult awarded its winners.
-
Anna Törner: To kill your darlings
Hopes were high when Anna Törner and her colleague started a study on a dietary supplement that seemed unbelievably good. “Enthusiastically, we dreamed of exciting results and perhaps a publication in a high-impact journal,” she writes in a column.
-
Hello Angelica Loskog!
Life Science Sweden would like to know more about Angelica Loskog and interviews her about her life as a researcher.
-
Noxious parasite forms hybrids and deceives the immune system
The small parasite Trypanosoma cruzi has a nasty ability to cause serious illness. Researchers at the Karolinska Institutet have now mapped its ability to deceive the immune system by forming new variants that are mixtures of different strains.
-
Investments worth 40 billion in the Öresund region – “A huge investment wave”
A new report reveals that medical companies in the Oresund region are investing like never before.
-
New rules for diagnostic products, but who will certify them? “An extreme shortage area”
In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and Covid-19. However, not one single institute in the entire Nordic region is able to certify the diagnostics companies’ products according to the new regulations. “In the end, it risks affecting patients,” says Anna Lefèvre Skjöldebrand, CEO of Swedish Medtech.
-
Karriärcoachen: Så minglar du bäst på kongressen – och får ett dolt jobb
Samhället har öppnat upp efter pandemin och konferenser, kongresser och Almedalen står på agendan. Men efter två år i en digital bubbla kan man känna sig ringrostig inför minglandet. Karriärcoachen Tina Persson tipsar om vad du ska tänka på inför det fysiska mötet.
-
Trio bakom Olink får pris från Uppsala universitetet
Personerna bakom Olink blir de första att ta emot det nya innovations- och entreprenörspriset från Uppsala universitet. Ulf Landegren, Björn Ekström och Jon Heimer får pris för att ”verka i universitetets anda för en bättre värld”.
-
Tougher competition as the Novo Nordisk Foundation broadens its programme
Søren Nedergaard has worked with innovation at the Danish Government Offices and the University of Copenhagen. Today, he is COO of the Novo Nordisk Foundation, which has recently broadened its programme for leading innovators in medical research to apply to the entire Nordic region.
-
Paolo Macchiarini in court – “The sole intent was to cure”
Paolo Macchiarini’s surgical procedure was illegal, life-threatening and caused severe and prolonged suffering to patients the prosecution claimed when the trial against the Italian surgeon began on Wednesday last week.
-
When carelessness, forgetfulness and coincidence become the researcher’s best friend
Forgetfulness, coincidence and a stroke of luck hardly make up a fruitful method of serious research. Or do they? Actually, a number of important medical advances have come about thanks to completely random incidents and the open-mindedness of scientists who were ready to think outside the box.
-
KTH föreslår Anders Söderholm som ny rektor
Universitetsstyrelsen föreslår att Anders Söderholm blir nästa rektor för Kungliga Tekniska Högskolan. Nuvarande rektor Sigbritt Karlsson, som började 2016, har valt att inte sitta ytterligare tre år på tjänsten.
BREAKING